NCT05369351View on ClinicalTrials.gov

Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

August 10, 2026

Study Completion Date

November 10, 2026

Conditions
Intracerebral Haemorrhage
Interventions
DRUG

Standard treatment+mirabegron

In addition to standard treatment, the first dose of mirabegron 50mg/day will be given within 72 hours of symptom onset and continued until the 7th day after onset.

OTHER

Standard treatment

Standard treatment

Trial Locations (1)

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University General Hospital

OTHER